Research & Innovation

Advancing pharmacy practice through evidence-based research and innovative technologies

Pitt-UPR Student Exchange Program Development

Professional Development

Contributing to the development of a student exchange program between the University of Pittsburgh and the University of Puerto Rico pharmacy schools, fostering professional relationships and cross-cultural pharmacy education.

Key Outcomes:

  • Advancing program development between two pharmacy schools
  • Fostering professional relationships in pharmacy education
  • Promoting cross-cultural pharmacy practice experiences
  • Enhancing international collaboration opportunities
Program DevelopmentProfessional NetworkingCross-Cultural Education

Virtual Reality in Pharmacy Education

Educational Technology

Developed VR cases using SimX to improve student pharmacist medication counseling and patient education skills. Tested and analyzed VR modules for PharmD curriculum, examining impact on experiential learning, interprofessional collaboration, and competency-based training.

Key Outcomes:

  • Developed VR case for medication counseling improvement
  • Tested SimX VR modules for curriculum enhancement
  • Analyzed impact on competency-based learning and critical thinking
  • Authored abstract on VR integration in pharmacy education
  • Presented findings at health disparities research competition
SimX VREducational TechnologyClinical SimulationCompetency Assessment

Publications:

  • Abre los Ojos para Escucharnos: Using Virtual Reality to Teach Social Determinants of Health

FDA Regulatory Science Research

Regulatory Affairs

U.S. Food and Drug Administration

Co-led an initiative to enhance industry understanding of critical regulatory calculations. Developed and presented scientific presentations translating complex regulatory data into clear visual insights for broader team discussions.

Key Outcomes:

  • Enhanced industry understanding of regulatory calculations
  • Developed clear data visualizations for complex regulations
  • Contributed to regulatory education initiatives
  • Improved scientific communication strategies
Data VisualizationRegulatory AffairsScientific CommunicationPresentation Design

Drug Metabolism & Transport Research

Pharmaceutical Science

Investigated PEG-ASNase's effects on drug metabolism and transport. Performed comprehensive literature review on asparaginase therapy's impact, identifying 15 key entries from a 27,000-entry dataset on cytochrome P450 and phase II enzymes.

Key Outcomes:

  • Generated key scientific insights for medical communications
  • Synthesized complex findings into scientific reports
  • Identified critical drug-enzyme interactions
  • Supported evidence-based medical information strategies
PharmacokineticsDrug MetabolismLiterature ReviewScientific WritingData Analysis
4
Research Projects
3+
Focus Areas
VR
Innovation
FDA
Experience

Presentations

Sharing insights on digital health, regulatory science, and pharmacy innovation

The Future is Remote

FDA Guidance & Regulatory Strategy for RPM in Drug Research

April 2025
Capstone PresentationFaculty, Students, Industry Professionals

Comprehensive analysis of FDA guidance for remote patient monitoring technologies in clinical drug research.

Remote Patient MonitoringFDA RegulationDigital HealthDrug Development

FDA Guidance on AI in Drug Regulatory Decision-Making

Critical Review & Applicability in Drug Development

March 2025
Academic SeminarPharmacy Students, Faculty

Critical review of FDA guidance on AI in regulatory decision-making and its implications for pharmaceutical development.

Artificial IntelligenceRegulatory ScienceDrug DevelopmentFDA Guidance

Abre los Ojos para Escucharnos

Using Virtual Reality to Teach Social Determinants of Health

March 2024
Poster PresentationUniversity Research Community

Poster presented at the 2024 Health Disparities & Social Justice Poster Competition, University of Pittsburgh.

Virtual RealitySocial Determinants of HealthHealth EducationHealth Disparities

Upcoming: More presentations scheduled for 2025. Stay tuned!